Raymond James analyst Steve Seedhouse upgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from Underperform to Market Perform.The analyst commented, "We’ll take our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE